
Cooper Companies (COO) Stock Forecast & Price Target
Cooper Companies (COO) Analyst Ratings
Bulls say
Cooper Companies is well-positioned for long-term success due to its strong market presence in both the contact lens and women's health industries. The company's segmented structure allows for diversification and potential growth opportunities, such as the recent launch of the non-hormonal IUD Miudella by subsidiary Sebela. The company's strategic actions, including a formal review and potential separation of its segments, also provide potential catalysts for future growth.
Bears say
Cooper Companies is facing competitive pressure and pricing headwinds in its contact lens business due to increased e-commerce competition, which is expected to impact their EPS growth in the near term. In addition, the company's flagship product Paragard, which accounts for a significant portion of its revenue, is facing potential competition from a new hormonal IUD in development by competitor Sebela, which could impact its market share in the long term. Furthermore, the company's recent strategic review may result in a separation of its two business segments, leading to potential dis-synergies and a negative impact on its tax rate.
This aggregate rating is based on analysts' research of Cooper Companies and is not a guaranteed prediction by Public.com or investment advice.
Cooper Companies (COO) Analyst Forecast & Price Prediction
Start investing in Cooper Companies (COO)
Order type
Buy in
Order amount
Est. shares
0 shares